Multiple-line Chemotherapy and Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer.

MLA

Zhang, Hua, et al. “Multiple-Line Chemotherapy and Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer.” Combinatorial Chemistry & High Throughput Screening, vol. 22, no. 1, 2019, pp. 27–34. EBSCOhost, https://doi.org/10.2174/1386207322666181231122030.

APA

Zhang, H., Yang, J., Deng, Y.-M., Zhao, N., Liang, J.-M., Yang, S., Zhang, S., & Feng, W.-N. (2019). Multiple-line Chemotherapy and Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer. Combinatorial Chemistry & High Throughput Screening, 22(1), 27–34. https://doi.org/10.2174/1386207322666181231122030

Chicago

Zhang, Hua, Jie Yang, Yan-Ming Deng, Ning Zhao, Jian-Miao Liang, Shuang Yang, Shun-da Zhang, and Wei-Neng Feng. 2019. “Multiple-Line Chemotherapy and Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer.” Combinatorial Chemistry & High Throughput Screening 22 (1): 27–34. doi:10.2174/1386207322666181231122030.